Literature DB >> 24604898

Free testosterone for hypogonadism assessment in HIV-infected men.

Anne K Monroe1, Todd T Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24604898      PMCID： PMC4072905          DOI： 10.1093/cid/ciu129

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Androgen deficiency and HIV infection.

Authors:  Steven Grinspoon
Journal:  Clin Infect Dis       Date:  2005-11-11       Impact factor: 9.079

2.  Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection.

Authors:  Anne K Monroe; Adrian S Dobs; Xiaoqiang Xu; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

3.  Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America.

Authors:  Judith A Aberg; Joel E Gallant; Khalil G Ghanem; Patricia Emmanuel; Barry S Zingman; Michael A Horberg
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

4.  Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism.

Authors:  Anne K Monroe; Adrian S Dobs; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Todd T Brown
Journal:  AIDS Res Ther       Date:  2014-01-22       Impact factor: 2.250
  4 in total
  2 in total

1.  Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.

Authors:  D Santi; B Madeo; F Carli; S Zona; G Brigante; F Vescini; G Guaraldi; V Rochira
Journal:  Osteoporos Int       Date:  2015-10-28       Impact factor: 4.507

Review 2.  A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.

Authors:  Anna L Goldman; Shalender Bhasin; Frederick C W Wu; Meenakshi Krishna; Alvin M Matsumoto; Ravi Jasuja
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 25.261
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.